As of 2026-11-20 00:04 UTC.Market figures are as the cited sources reported them at that time and may have moved since. This is news, not investment advice.
Alnylam Pharmaceuticals (NASDAQ: ALNY) stock fell $58.40, or 25.13%, to close at $174.00 on October 29, 2026 following the earnings release.[1]